Posts tagged ‘Boehringer Ingelheim’

FDA approves Pradaxa to prevent stroke in people with atrial fibrillation

On Tuesday, the FDA approved Boehringer Ingelheim’s Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).